NPPB and heart failure: Both the Aliskiren Observation of Heart failure Treatment (ALOFT) study and the Aliskiren Trial on Acute Heart failure Outcomes (ASTRONAUT) study have showed that aliskiren significantly decreased NT-proBNP and BNP levels, but the patients’ outcomes were not improved.